The Food & Drug Administration is bringing a whole new constituency into the advisory committee process with the creation of an expert panel focused on improving the way the agency conveys risk information to the public.
The creation of the Risk Communication Advisory Committee is the latest in FDA’s measured rollout of many of the Institute...